Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Molecular Psychiatry
|
April 28, 2001
Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders
T C Baghai, C Schüle, P Zwanzger, et al.
Psychoneuroendocrinology
|
February 8, 2003
The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression
P Zwanzger, T C Baghai, F Padberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 18, 2003
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study
P Zwanzger, D Eser, S Aicher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 30, 2001
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers
P Zwanzger, T C Baghai, C Schuele, et al.
Molecular Psychiatry
|
May 5, 2004
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression
P Zill, T C Baghai, P Zwanzger, et al.
Neuroscience
|
November 29, 2005
Neuroactive steroids as modulators of depression and anxiety
D Eser, E Romeo, T C Baghai, et al.
Molecular Psychiatry
|
December 12, 2002
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease?
B Bondy, T C Baghai, P Zill, et al.
Journal of Psychiatric Research
|
February 6, 2004
Neuroactive steroids are not affected by panic induction with 50 microg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers
P Zwanzger, D Eser, F Padberg, et al.
Molecular Psychiatry
|
December 14, 2005
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity
C Schüle, E Romeo, D P Uzunov, et al.
Current Pharmaceutical Design
|
December 17, 2008
Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4
A C Dieler, P G Sämann, G Leicht, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Molecular Psychiatry
|
April 28, 2001
Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders
T C Baghai, C Schüle, P Zwanzger, et al.
Psychoneuroendocrinology
|
February 8, 2003
The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression
P Zwanzger, T C Baghai, F Padberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 18, 2003
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study
P Zwanzger, D Eser, S Aicher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 30, 2001
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers
P Zwanzger, T C Baghai, C Schuele, et al.
Molecular Psychiatry
|
May 5, 2004
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression
P Zill, T C Baghai, P Zwanzger, et al.
Neuroscience
|
November 29, 2005
Neuroactive steroids as modulators of depression and anxiety
D Eser, E Romeo, T C Baghai, et al.
Molecular Psychiatry
|
December 12, 2002
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease?
B Bondy, T C Baghai, P Zill, et al.
Journal of Psychiatric Research
|
February 6, 2004
Neuroactive steroids are not affected by panic induction with 50 microg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers
P Zwanzger, D Eser, F Padberg, et al.
Molecular Psychiatry
|
December 14, 2005
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity
C Schüle, E Romeo, D P Uzunov, et al.
Current Pharmaceutical Design
|
December 17, 2008
Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4
A C Dieler, P G Sämann, G Leicht, et al.
Page
of 4